Search

Your search keyword '"Adoue, Daniel"' showing total 194 results

Search Constraints

Start Over You searched for: Author "Adoue, Daniel" Remove constraint Author: "Adoue, Daniel"
194 results on '"Adoue, Daniel"'

Search Results

3. The CARMEN-France registry of adult patients with immune thrombocytopenia and autoimmune hemolytic anemia in France

6. Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study

9. Les auteurs

13. An appraisal of the frequency and severity of noninfectious manifestations in primary immunodeficiencies: A study of a national retrospective cohort of 1375 patients over 10 years

14. A case-control study to assess the risk of immune thrombocytopenia associated with vaccines

15. Autoimmune and inflammatory manifestations occur frequently in patients with primary immunodeficiencies

17. Sine Scleroderma, Limited Cutaneous and Diffused Cutaneous Systemic Sclerosis Survival and Predictors of Mortality

18. Additional file 1 of Sine scleroderma, limited cutaneous, and diffused cutaneous systemic sclerosis survival and predictors of mortality

19. Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic Sclerosis: A Randomized Clinical Trial

24. Primary immune thrombocytopenia in very elderly patients: particularities in presentation and management: results from the prospective CARMEN‐France Registry.

25. Genetic diagnosis of primary immunodeficiencies: A survey of the French national registry

27. Eltrombopag in adult patients with immune thrombocytopenia in the real‐world in France, including off‐label use before 6 months of disease duration: The multicenter, prospective ELEXTRA study.

29. Positivity Rate of Systematic Bone Marrow Smear Above 60-Year-Old Patients with Newly Diagnosed Immune Thrombocytopenia to Screen for Associated Hematological Malignancy. Results from the French Prospective Multicenter Carmen Registry

30. Immune Thrombocytopenia in Very Elderly Patients: Particularities in Presentation and Management. Results from the Multicenter Prospective Carmen-France Registry

31. Genetic diagnosis of primary immunodeficiencies: A survey of the French national registry

33. Outcome after failure of allogeneic hematopoietic stem cell transplantation in children with acute leukemia: a study by the société Francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC)

34. Pattern of myocardial 99mTc-HMDP uptake and impact on myocardial function in patients with transthyretin cardiac amyloidosis.

35. Impact of micronutrient deficiency & malnutrition in systemic sclerosis: Cohort study and literature review

36. Zoster after Cyclophosphamide for Systemic Lupus Erythematosus or Vasculitis: Incidence, Risk Factors, and Effect of Antiviral Prophylaxis

37. Re: Severe Primary Autoimmune Thrombocytopenia (ITP) in Pregnancy: a national cohort study Primary immune thrombocytopenia management during pregnancy. A French study

38. Risk of autoimmune diseases and human papilloma virus (HPV) vaccines: Six years of case-referent surveillance

39. Positivity Rates of Tests Used at Immune Thrombocytopenia Diagnosis to Detect Associated Diseases. a Prospective Multicenter Cohort Study of 218 Patients

41. Interest in Initiating Corticosteroids By Intravenous Methylprednisolone at Standard Dose in Newly Diagnosed Immune Thrombocytopenia Adults: Results of the Prospective Carmen Registry

42. A 1-Year Prospective French Nationwide Study of Emergency Hospital Admissions in Children and Adults with Primary Immunodeficiency.

44. Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic Sclerosis

45. Risk factors associated with intracranial hemorrhage in adults with immune thrombocytopenia: A study of 27 cases

47. Incidence of Adverse Drug Reactions Related to Immune Thrombocytopenia Drugs. A Prospective Cohort Study

48. Clinical Epidemiology and First-Line Treatment in Immune Thrombocytopenia Adults. Results of the Carmen Prospective Cohort

50. Pretreatment with standard‐dose intravenous methylprednisolone does not improve outcomes in newly diagnosed immune thrombocytopenia (ITP).

Catalog

Books, media, physical & digital resources